Literature DB >> 24481993

Do we still need studies on the value of the TIVAD for cancer patients?

Isidoro Di Carlo1, Adriana Toro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24481993     DOI： 10.1007/s00268-014-2466-6

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  2 in total

1.  Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications.

Authors:  I Di Carlo; S Cordio; G La Greca; G Privitera; D Russello; S Puleo; F Latteri
Journal:  Arch Surg       Date:  2001-09

2.  Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.

Authors:  Kul Ranjan Singh; Gaurav Agarwal; Gitika Nanda; Gyan Chand; Anjali Mishra; Amit Agarwal; Ashok K Verma; Saroj K Mishra; Puneet Goyal
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352
  2 in total
  1 in total

1.  Comparison between ultrasound-guided TIVAD via the right innominate vein and the right internal jugular vein approach.

Authors:  Xingwei Sun; Xuming Bai; Jiaofeng Shen; Ziyang Yu; Zhixiang Zhuang; Yong Jin
Journal:  BMC Surg       Date:  2019-12-11       Impact factor: 2.102
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.